370 related articles for article (PubMed ID: 10364038)
1. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
4. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
5. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
[TBL] [Abstract][Full Text] [Related]
6. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
9. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
10. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
11. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
12. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
14. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
Navaneethan U; Venkatesh PG; Mukewar S; Lashner BA; Remzi FH; McCullough AJ; Kiran RP; Shen B; Fung JJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):540-6. PubMed ID: 22245961
[TBL] [Abstract][Full Text] [Related]
15. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
16. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
18. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
[TBL] [Abstract][Full Text] [Related]
19. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
